Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153193 | SCV000202664 | benign | not specified | 2014-01-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000528324 | SCV000636580 | benign | Kleefstra syndrome 1 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618308 | SCV001847227 | benign | not provided | 2019-02-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415647 | SCV002718786 | likely benign | Inborn genetic diseases | 2017-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001618308 | SCV004164070 | likely benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | EHMT1: BP4, BP7 |
Breakthrough Genomics, |
RCV001618308 | SCV005318156 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003927478 | SCV004744093 | benign | EHMT1-related disorder | 2019-05-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |